Triangulation of Innovative Methods to End Alzheimers Disease

Research on Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) has identified several promising risk factors which could guide strategies to prevent up to 45% of AD/ADRD.

By systematically comparing results from different study designs and populations we will provide more rigorous evidence than previously possible and help fill a priority research gap in the National Plan to Address Alzheimer’s Disease.

TIME-AD Leadership

Our investigator team brings years of expertise in multiple data sources, analytic methods, health equity, and evidence dissemination and integration of evidence.

Wang J, Hill-Jarrett T, Buto P, Pederson A, Sims KD, Zimmerman SC, DeVost MA, Ferguson E, Lacar B, Yang Y, Choi M, Caunca MR, La Joie R, Chen R, Glymour MM, Ackley SF. Comparison of approaches to control for intracranial volume in research on the association of brain volumes with cognitive outcomes. Hum Brain Mapp. 2024 Mar;45(4):e26633. doi: 10.1002/hbm.26633. PMID: 38433682; PMCID: PMC10910271.

“It is not enough to possess knowledge; we must apply it. It is not enough to desire a better world; we must create it.”

— Dr. Jonas Salk

Thank You to the National Institute on Aging (NIA)

We are deeply grateful to the National Institute on Aging (NIA) for their generous support and commitment to advancing research that seeks to improve the health and well-being of older adults. The award of P01AG082653-01A1 allows us to pursue innovative solutions and deepen our understanding of AD/ADRD - a mission that aligns with NIA’s dedication to improving quality of life as we age.

With this funding, we are able to further our research and move closer to impactful outcomes that will benefit individuals, families, and communities. We extend our heartfelt thanks to NIA for their trust in our work and their unwavering support in promoting healthier aging for all.

Contact us.

timead@bu.edu